GCT is proud to announce the award of a new medical device study in Romania focused on evaluating the safety of an innovative breakthrough technology for the non-invasive and non-thermal treatment of varicose veins.
Under this new partnership with VeinSound SAS, GCT will oversee monitoring activities for the project, ensuring high-quality clinical oversight throughout the study lifecycle. In addition, we offer functional service provider model to support additional clinical trial activities as needed throughout the study. This scalable approach allows sponsors to leverage GCT’s broader operational expertise as project requirements evolve.
This award further strengthens GCT’s growing track record in medical device clinical research and expands our portfolio of successful device programs across multiple therapeutic areas. GCT has previously supported medical device studies in Women’s Health, Ophthalmology, CNS, and other clinical domains, delivering strong execution and tailored CRO support across diverse technologies.
As demand for less invasive vascular treatment solutions continues to rise, GCT is honored to contribute to the advancement of next-generation technologies that aim to improve patient outcomes and expand treatment options.
This new project reflects GCT’s continued commitment to supporting innovative sponsors with flexible, reliable clinical operations across both pharmaceutical and medical device development.